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Abstract
Background: Following hepatic resection, liver regeneration has been associated with concurrent
splenic hypertrophy. The mechanisms of this phenomenon are unknown, may be multiple and include:
splanchnic sequestration caused by a reduction in the hepatic mass; hepatic growth factors that may
indirectly act on the spleen, and the redistribution of the total reticuloendothelial system.
Methods: Seventy-five patients (40 males; median age: 60 years) who underwent minor (16%) or major
(84%) hepatectomy between September 2004 and October 2009 were included. Prospective measure-
ments of liver and spleen volumes were obtained preoperatively and postoperatively 1 month after
hepatectomy using computed tomography (CT). The future remnant liver volume (RLV) was calculated on
preoperative CT and the extent of resection was expressed as the RLV divided by total liver volume (TLV).
Liver and spleen hypertrophy were expressed according to the absolute gain or relative increase in the
initial volumes (%).The presence of fibrosis >F1, associated extrahepatic resection (except minor resec-
tions), and previous hepatectomy (major or minor) within 3 months represented exclusion criteria.
Results: Mean  standard deviation (SD) liver volume at 1 month was higher than RLV (1187  286 cm3
versus 764 421 cm3; P < 0.001). Mean SD splenic volume increased from 252 100 cm3 preoperatively
to 300  111 cm3 at 1 month (P < 0.001). Liver and splenic hypertrophy were significant after major
hepatectomies (+100% and +26%, respectively; P < 0.001), but not after minor hepatectomies. Liver hyper-
trophy was inversely correlated to RLV/TLV (r = -0.687, P < 0.001). Splenic hypertrophy was not correlated to
RLV/TLV. Liver and splenic hypertrophy were linearly correlated (r = 0.495, P < 0.001). Neoadjuvant chemo-
therapy (n = 37), preoperative portal vein embolization (n = 10) and postoperative complications (overall:
n = 25; major: n = 10; infectious: n = 6) had no impact on hepatic or splenic hypertrophy.
Conclusions: Splenic hypertrophy occurred after major hepatectomy, but was not correlated to the
extent of resection, by contrast with liver hypertrophy. Nevertheless, there was a linear correlation
between splenic and liver hypertrophy. This correlation suggests the hypothesis of a splenic action of
hepatic growth factors or a redistribution of the total reticuloendothelial system rather than an effect of
reduction of the portal bed or hepatic outflow.
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Introduction
The spleen is capable of regeneration after partial splenectomy
or autotransplantation of splenic fragments following
splenectomy,1–3 although the regenerative process in the spleen is
not as important as that in the liver. Splenic hypertrophy has also
been described following hepatic resections, mainly following
living donor liver transplantation (LDLT), leading to postopera-
tive hypersplenism and thrombocytopoenia in living liver
donors.4,5 Kamel et al. noted that in all their donors, the spleen
increased in volume in the immediate postoperative period,
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reaching a peak of 45% at 1 month, followed by a plateau for up to
6 months, and then a gradual decline so that it returned to the
preoperative volume after approximately 1 year.6 In those compli-
ant with full 1-year follow-up, five of 22 donors were noted to have
persistent asymptomatic thrombocytopoenia beyond the periop-
erative period (90 days).5 Similarly, in a study by Ishizawa et al.,7
the ratio of splenic hypertrophy was 133% (range: 99–191%) and
was associated with a platelet count decrease of 92% (range:
71–129%). Splenic hypertrophy has been less studied in the
setting of hepatic resection for either malignant tumours or non-
malignant disease.8 The mechanisms of this phenomenon are
unknown. Several hypotheses have been advanced to explain this
splenic hypertrophy, including: splanchnic sequestration caused
by a reduction in the hepatic mass;9,10 hepatic growth factors that
may indirectly act on the spleen,4,11 and the redistribution of the
total reticuloendothelial system.12,13
The aim of this study was to analyse splenic hypertrophy after
liver resection. Secondly, the relationship between splenic hyper-
trophy and liver regeneration was analysed and factors predictive
of postoperative splenic hypertrophy were investigated.
Materials and methods
Patients, surgical technique and indications
All clinical, biological and morphological information concerning
patients who underwent hepatic resection in the Department of
Digestive Surgery and Transplantation, University Hospital, Lille,
France, were collected in a prospective database. Medical records
for all hepatectomies performed between September 2004 and
October 2009 were retrospectively analysed and all eligible
patients were included in the study. All included patients had
undergone computed tomography (CT) as part of their preopera-
tive assessment. No patient had a background of chronic liver
disease. Exclusion criteria were: liver fibrosis of >F114 on his-
topathological analysis; associated extrahepatic resection (except
minor resections); previous hepatectomy (major or minor within
3 months of the study period), and lack of available preoperative
volumetry (Fig. 1). After the inclusion of 40 patients, an interme-
diate analysis showed no significant change between the initial
and final volumes (of the liver and spleen) in the group that had
undergone minor hepatectomy. For this reason, only patients
undergoing major hepatectomy were included in the present
study.
Surgery for liver tumours was based on segment-oriented ana-
tomical resection.15 The extent of liver resection was defined
according to the number of liver segments resected as minor (one
or two Couinaud16 segments were resected or a wedge resection
was performed) or major (three or more segments were resected).
Most resections were performed under low central venous pres-
sure (3–5 cm H2O) without hepatic inflow occlusion or with
intermittent portal triad clamping (clamping periods of 15 min
separated by 5 min of release). Liver transection was performed
using an ultrasonic dissector (Dissectron®; Satelec Medical, Inte-
gra™, Mérignac, France).
Liver and splenic volumetry
Volumetric measurements of the liver and spleen were obtained
using methods previously reported.17–20 Briefly, serial transverse
images of the upper abdomen were obtained at intervals of 4.5–
6.0 mm, with enhancement by i.v. bolus injection of contrast
medium. On each slice of the preoperative CT, the total liver
volume (TLV), the remnant liver volume (RLV) and the splenic
volume (SV) were traced with the cursor and the sum of the slices
was calculated using integrated software (Fig. 2). This preopera-
tive CT was performed at1 month prior to hepatectomy or after
preoperative portal vein embolization (PVE) when the latter was
performed. The RLV and SV were also measured after surgery
within 4–6 weeks in all patients (RLVM1 and SVM1).7
The extent of liver resection was evaluated according to either
the ratio of RLV to TLV (RLVTLV, expressed as a percentage of TLV)
or by the ratio of RLV to body weight (RLVBW, expressed as a
percentage of body weight). Liver and spleen hypertrophy were
calculated in two manners to show, respectively, absolute and
relative increases. The absolute increase was defined as the differ-
ence between volume at 1 month and preoperative volume,
expressed in cubic centimetres as RLVincrease = RLVM1 - RLV for the
liver, and SVincrease = SVM1 - SV for the spleen. The relative increase
was defined as the ratio between the absolute increase and preop-
erative volume, expressed as a percentage, as RLVincrease% =
(RLVincrease/RLV) ¥ 100 for the liver and SVincrease% = (SVincrease/SV) ¥
100 for the spleen. The ratios of SV to RLV before and after surgery
were also calculated as SV/RLV and SVM1/RLVM1, respectively.7
Postoperative outcome and follow-up
Morbidity was defined as any perioperative complication occurring
during the same hospital stay or within 3 months following resec-
tion. This category included surgical complications (bleeding from
the surgical site or bile leak), hepatic, cardiovascular, respiratory or
Patients who underwent hepatic
resection between September
2004 and October 2009:
n = 574 (major resection: n = 265)
75 patients included:
403 patients
Liver fibrosis
Excluded
Previous hepatectomy (within 3
months): n = 8
Associated extrahepatic resection
of primary tumour: n = 13
Lack of available preoperative
volumetry: n = 307
395 patients
382 patients
F0: n = 64
F1: n = 11
F2: n = 36
F3: n = 38
F4: n = 97
Figure 1 Flow chart showing details of the patient selection process
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renal dysfunction, and infection. Only clinically significant infec-
tions were taken into account; these were defined by coincident
findings of a positive microbial culture and either local or general
symptoms of inflammation.21–23 Complications were categorized
into five grades according to the Dindo–Clavien system of classifi-
cation24 and defined as major when they required interventional
radiology or reoperation (Dindo–Clavien Grade III) or resulted in
organ(s) failure (Dindo–Clavien Grade IV) or patient death
(Dindo–Clavien Grade V). Common blood cell counts and liver
function tests were examined before surgery and on postoperative
days 1, 3, 5 and 7. The biochemical and clinical courses of patients
were studied for their associations with liver and spleen volumes,
and the respective extents of hypertrophy of these organs at 1 month.
Statistical analysis
Continuous variables are expressed as the median, mean and
range; qualitative variables are expressed as frequencies (percent-
ages). The Shapiro–Wilk normality test was used to choose
between parametric and non-parametric tests. Parametric tests
were used for normal distributions. Otherwise, non-parametric
tests were chosen. The evolution in SV at 1 month after hepatec-
tomy (SVM1) and the evolution in liver volume at 1 month after
hepatectomy (RLVM1) were tested using a paired t-test and a Wil-
coxon signed-rank test, respectively. Continuous variables were
compared between type of resection (major or minor hepatec-
tomy) and the resected portal branch (right or left) using the
Mann–Whitney U-test. Correlations between continuous vari-
ables were measured using Pearson’s correlation coefficient. To
identify variables predictive of splenic hypertrophy within 4–6
weeks after surgery (SVM1), all analyses were adjusted on SV.
Preoperative, intraoperative and early postoperative (up to day 7)
variables for all patients were analysed using a linear regression
method for continuous variables and analysis of covariance
(ancova) for qualitative variables. In order to study whether the
kinetics of biological parameters can influence changes in SV, this
analysis included the extreme values (minimum and maximum)
of these parameters. All variables with a P-value of <0.2 in the
previous analysis were introduced in a multiple linear regression
with stepwise selection to identify a subset of independent pre-
dictive factors of SVM1 adjusted on SV. Influential individuals were
sought using Cook’s distance estimates and the normality of
standardized residuals was checked to validate the final regression
model. All analyses were performed using sas Version 9.2 (SAS
Institute, Inc., Cary, NC, USA). A P-value of <0.05 was considered
to indicate statistical significance.
Results
Study population
Seventy-five patients were included in the study; their principal
characteristics are shown in Table 1. Hepatectomy was performed
for malignant tumours in 69 patients (92%); diagnoses in these
patients referred to colorectal cancer liver metastases in 44 (59%)
patients, other secondary malignancies in six (8%) patients, hepa-
tocellular carcinoma in eight (11%) patients, cholangiocarcinoma
in nine (12%) patients, sarcoma in one (1%) patient and gallblad-
der cancer in one (1%) patient. Other indications for hepatectomy
were focal nodular hyperplasia in two (3%) patients, adenoma in
three (4%) patients and haemangioma in one (1%) patient. Addi-
tional procedures were performed in seven (9%) patients. These
included adrenalectomy in one patient, eventration repair in two
patients, colorectal anastomosis in one patient, small intestine
suture in one patient, embolectomy for thrombosis of an arterio-
(a)
(b)
Figure 2 Computed tomography in a 46-year-old woman with meta-
chronous colorectal cancer liver metastases. (a) Preoperative vol-
umetry. The limits of the liver (resected liver in green, remnant liver in
red) and spleen (yellow) were traced with the cursor and the sum of
the 5-mm slices was calculated using integrated software. (b) Post-
operative volumetry at 6 weeks after left hepatectomy shows an
increase in spleen volume
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venous fistula for haemodialysis in one patient, and subcutaneous
lipoma removal in one patient. Three (4%) patients died, all after
the 1-month volumetric evaluation.
Overall volumetric data
Volumetric data for all patients are shown in Table 2. There was a
statistically significant increase in SV at 1 month after hepatec-
tomy, with a mean increase of 24% of the initial volume (P <
0.001). Similarly, there was a statistically significant increase in
liver volume at 1 month, with a mean increase of 85% of the initial
volume (P < 0.001). The ratio of SV to RLV measured on preop-
erative CT was significantly greater than the ratio of SV to RLV at
1 month (P < 0.001).
Significant increases in spleen (P < 0.001) and liver (P < 0.001)
volumes were noted in patients after major hepatectomies
(Table 2). In the minor hepatectomy group, there was no significant
difference between preoperative volume and volume at 1 month in
either the spleen or liver (P = 0.158 and P = 0.182, respectively).
Stratification by portal branch resection (right or left)
Patients who underwent a major hepatectomy were divided into
two groups according to whether the left or right portal branch
had been resected. The increase in liver volume was significantly
higher (P < 0.001) in patients subjected to right portal branch
resection (median: 102%; mean: 117%; range: 14–395%) than in
those submitted to left portal branch resection (median: 19%;
mean: 15%; range: -17% to 59%), which relates to a smaller RLV
in the former group. By contrast, despite the disparity in RLV,
there was no significant difference in spleen hypertrophy between
patients undergoing right portal branch resection (median: 18%;
mean: 26%; range: -48% to 186%) and those undergoing left
portal branch resection (median: 29%; mean: 30%; range: -14%
to 95%) (P = 0.473).
Correlation with the extent of resection
Liver hypertrophy, expressed as the RLVincrease%, was inversely cor-
related to postoperative RLVTLV (Pearson’s correlation coeffi-
cient: -0.687; P < 0.001) (Fig. 3). Splenic hypertrophy (SVincrease%)
was not correlated to the extent of liver resection (Pearson’s
correlation coefficient: -0.142; P = 0.224) (Fig. 4). However,
liver and splenic hypertrophy were linearly correlated to one
another (Pearson’s correlation coefficient: 0.495; P < 0.001)
(Fig. 5).
Table 1 Principal characteristics of the study population (n = 75)
Age, years, median, mean (range) 60, 60 (34–85)
Body mass index, kg/m2, median, mean (range) 25.1, 26.1 (17.0–38.6)
Gender, n (%) Female 35 (46.7%)
Male 40 (53.3%)
ASA physical status, n (%) 1 25 (33.3%)
2 38 (50.7%)
3 12 (16.0%)
Preoperative chemotherapy, n (%) 37 (49.3%)
Indications, n (%) Metastases 50 (66.7%)
Liver cancera 19 (25.3%)
Non-malignant 6 (8.0%)
Portal vein embolization, n (%) 10 (13.3%)
Major hepatectomy, n (%) 63 (84.0%)
Resected nodules/patient, median, mean (range) 1, 2 (1–10)
Resected segments/patient, median, mean (range) 4, 4 (0–6)
Clamping, n (%) 33 (44.0%)
Total ischaemia, min, median, mean (range) 0, 15 (0–96)
Blood loss, ml, median, mean (range) 525, 657 (50–3500)
Intraoperative blood transfusion, n (%) 4 (5.3%)
Operative time, min, median, mean (range) 285, 294 (60–580)
Morbidity, n (%) Overall 25 (33.3%)
Major (Clavien Grades III, IV) 10 (13.3%)
Infectious 6 (8.0%)
Duration of ICU stay, days, median, mean (range) 2, 4 (0–97)
Duration of hospitalization, days, median, mean (range) 8, 12 (4–97)
aIncludes hepatocellular carcinoma, cholangiocarcinoma, sarcoma and gallbladder cancer.
ASA, American Society of Anesthesiologists; ICU, intensive care unit.
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Predictors of splenic hypertrophy
Factors associated with splenic hypertrophy on bivariate analysis
are shown in Tables 3 and 4.
In multivariate analysis, the independent predictive factors of
postoperative splenic hypertrophy were: preoperative haemo-
globin (P = 0.047); intraoperative blood loss (P < 0.001), and
postoperative maximum bilirubin (P < 0.001).
Discussion
The present study described a significant increase of 24% in SV
after partial hepatectomy that occurred only after major hepatec-
Table 2 Volumetric data
Variables Total sample (n = 75)
Median, mean (range)
Major hepatectomy (n =
63) Median, mean (range)
Minor hepatectomy (n =
12) Median, mean (range)
SV, cm3 242, 252 (87–551) 242, 250 (87–551) 228, 258 (130–463)
TLV, cm3 1646, 1827 (845–5650) 1670, 1877 (1023–5650) 1521, 1567 (845–2923)
TLV/BW, % 2.2, 2.4 (1.2–7.6) 2.2, 2.5 (1.2–7.6) 2.1, 2.3 (1.5–4.4)
SV/RLV, % 39.1, 40.7 (11.0–128.0) 41.8, 44.5 (11.0–128.0) 17.6, 20.2 (13.0–42.0)
SV/TLV, % 13.9, 14.5 (3.4–32.2) 13.5, 14.1 (3.4–32.2) 15.9, 17.1 (8.5–31.6)
SV/BW, % 0.3, 0.3 (0.1–0.7) 0.3, 0.3 (0.1–0.7) 0.3, 0.4 (0.2–0.7)
RLV, cm3 607, 763 (158–2024) 562, 663 (158–2024) 1292, 1291 (799–1784)
RLV/TLV, % 36.9, 43.9 (13.9–98.1) 31.7, 36.2 (13.9–76.7) 87.7, 84.5 (60.6–98.1)
RLV/BW, % 0.8, 1.0 (0.2–2.7) 0.7, 0.8 (0.2–2.6) 1.7, 1.9 (1.4–2.7)
RLVM1, cm3 1142, 1186 (545–1878) 1098, 1154 (545–1781) 1357, 1356 (888–1878)
SVM1, cm3 290, 300 (83–610) 302, 304 (83–610) 233, 277 (145–520)
SVM1/RLVM1, % 22.7, 25.9 (9.7–57.5) 24.2, 27.0 (9.7–57.5) 19.5, 20.4 (12.7–39.4)
RLVM1/BW, % 1.5, 1.6 (0.8–2.7) 1.5, 1.5 (0.8–2.7) 2.1, 1.9 (1.5–2.4)
SVM1/BW, % 0.4, 0.4 (0.1–0.8) 0.4, 0.4 (0.1–0.8) 0.4, 0.4 (0.2–0.8)
RLVincrease, cm3 467, 422 (-243 to 1018) 502, 491 (-243 to 1018) 93, 64 (-219 to 325)
RLVincrease% 82.1, 85.5 (-17 to 395) 94.8, 100.3 (-17 to 395) 7.0, 7.1 (-12 to 33)
SVincrease, cm3 41, 48 (-197 to 225) 44, 53 (-197 to 225) 24, 19 (-71 to 106)
SVincrease% 17.8, 23.8 (-48 to 186) 18.2, 26.5 (-48 to 186) 12.1, 9.7 (-23 to 26)
SV, spleen volume; TLV, total liver volume; BW, body weight; RLV, remnant liver volume, M1, at 1 month.
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Figure 3 Correlation between liver hypertrophy (RLVincrease%) and the
extent of liver resection [as reflected by the remnant liver volume
(RLV)] expressed as a percentage of total liver volume (TLV). Pear-
son's correlation coefficient: -0.687 (P < 0.0001)
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Figure 4 Correlation between spleen hypertrophy (SVincrease%) and
the extent of liver resection [as reflected by the remnant liver volume
(RLV)] expressed as a percentage of total liver volume (TLV). Pear-
son's correlation coefficient: -0.142 (P = 0.224)
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tomy and was linearly correlated to hepatic hypertrophy. By
bivariate analysis, predictors of splenic hypertrophy included
preoperative SV/TLV and haemoglobin level, intraoperative blood
loss and transfusion requirements, and, postoperatively, the main
indicators of liver function (bilirubin, albumin, factor V and
platelet count). By contrast, splenic hypertrophy was not influ-
enced by the extent of resection, preoperative chemotherapy or
PVE, or postoperative complications. In a multivariate analysis,
only preoperative haemoglobin, intraoperative blood loss and the
postoperative peak of bilirubin were independent predictors of
splenic hypertrophy.
The spleen has been shown to be capable of regeneration after
partial splenectomy or autotransplantation.1–3,25 Nevertheless, the
mechanism for its growth is unknown and may differ from that
observed after hepatic resection. This study demonstrates a mean
 standard deviation (SD) increase in SV of 23.8 33.9% of the
original volume after hepatic resection. Accordingly, previous
studies in LDLT reported increases in spleen volume of 30–50%
from baseline at 1–6 months postoperatively.6,26–28 There have also
been a few reports of splenic hypertrophy after partial hepatec-
tomy in small patient cohorts.11 In 41 patients with colorectal liver
metastases, Jacobs et al.8 showed an increase in SV of 26% on the
first postoperative CT (P < 0.0001). In 24 patients with biliary
cancer, Ando et al.11 showed that SV increased to a mean SD of
155  40% of preoperative volume by 14 days after hepatectomy
and to a mean SD of 179 41% of preoperative volume by 28
days. In the current series of 75 patients, the biggest series to have
been reported to date, the rate of splenic hypertrophy was com-
parable with that found by Jacobs et al.,8 but weaker than that
observed by Ando et al.11 In this latter study of extended hepate-
ctomies (more than four segments), splenic hypertrophy may
have been accentuated by some degree of hepatic fibrosis second-
ary to preoperative cholestasis, although this was not specified by
the authors. Consequently, a significant negative correlation was
found between SV and platelet counts at 1 year after hepatec-
tomy.11 Because of its retrospective pattern, the current series did
not allow for an analysis of platelet count during the first postop-
erative year as this was not measured in all patients.
In the current study, the increase in SV occurred only after
major hepatic resection and reached as much as a mean  SD of
26.5 35.9% of the original volume. In this subgroup of patients,
liver volume at 1 month increased to a mean  SD of 100.4 
69.9% of RLV. By contrast, no significant liver or spleen hypertro-
phy was noted after minor hepatectomies. Similarly, in the study
by Jacobs et al.,8 the subgroup of patients who demonstrated no
increase or even a slight decrease in SV postoperatively tended to
have undergone hepatectomies of smaller volumes than patients
who demonstrated an increase in SV.8 However, in the current
series, splenic hypertrophy was not significantly correlated to the
extent of liver resection. By contrast, there was a significant linear
correlation between rates of splenic and liver hypertrophy in
favour of common regulatory factors. Similarly, Ando et al.11
reported a strong correlation between rates of increase in liver and
spleen volumes at 14 days after major hepatectomy. Interestingly,
two experimental studies3,29 reported that hepatectomy stimulates
DNA synthetic activity in the spleen, compatible with the hypoth-
esis of common stimulating growth factors.30–34
Alternatively, the increase in SV after hepatectomy may reflect a
mechanism that maintains the total body reticuloendothelial
system (RES),11 for which the liver and spleen are important com-
ponents.3 In a lymphatic translocation model of endotoxinaemia,
the liver was shown to play an important role in ensuring the
clearance of bacteria and their products from systemic circula-
tion.35 After a liver resection, gut bacterial translocation increases
the demands on the hepatic RES to keep the systemic circulation
sterile.36,37 In addition, significant increases in phagocytosis capac-
ity have been shown at extrahepatic sites such as the spleen and
lungs.12,13 Such findings have been accompanied by a change in
cytokine gene induction in the liver and spleen: for example,
tumour necrosis factor-a (TNF-a), an immune activator, was
induced at the transcriptional level in the spleen of partially hepa-
tectomized rats.38 In the current study, the fact that the main
indicators of liver function were predictors of spleen hypertrophy
supports this hypothesis as there is a strong relationship between
liver function and risk for postoperative sepsis.39 Although the
present authors found no relationship between spleen hypertro-
phy and septic complications, it can be assumed that liver RES
may be deficient – and insufficiently compensated by spleen RES,
resulting in sepsis – in extended hepatectomies only.40,41
A last hypothesis for post-hepatectomy splenic hypertrophy is
splanchnic sequestration caused by a reduction in the hepatic
mass available for the egress of splanchnic flow or in the hepatic
outflow. However, only 60% of sinusoids are functioning in the
steady state.42 After major hepatectomy, portal venous pressure
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Figure 5 Correlation between spleen hypertrophy (SVincrease%) and
liver hypertrophy (RLVincrease%) in the 75 patients. Pearson's correla-
tion coefficient: 0.495 (P < 0.0001)
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has been shown to increase,9,10 but the increase was reported to be
small, at <4–5 cm H2O. Furthermore, in serial measurements,
portal pressure was temporarily elevated at 3–5 days after surgery
and returned to preoperative values at an early stage after hepa-
tectomy.43,44 Because there are fewer sinusoidal vascular beds in
the hepatic islands at the beginning of the regeneration process,
transient narrowing of the sinusoids caused by the increasing
number of hepatocytes was assumed to contribute to this
change.44 Thus, passive congestion arising from increased portal
venous pressure may be of only limited importance as a mecha-
nism of splenic hypertrophy.11 In addition, a recent study showed
that tissue stiffness of the remnant liver after donor hepatectomy,
as assessed by virtual touch tissue quantification (VTTQ),
increased until postoperative days 3–5, and values in patients with
a small RLV were significantly higher than those in patients with a
large RLV.45 It was assumed by the authors that the formation of
hepatic islands leads to an increase in cellular density.46 The VTTQ
values of the spleen also increased and were similarly more pro-
nounced in the group of patients with a small RLV.45 A significant
positive correlation was observed between the postoperative
Table 3 Bivariate analysis of factors associated with spleen hypertrophy, adjusted on baseline
Categorical variables n Spleen volumeincrease%Median,
mean (range)
P-valuea
Genderb Female 35 20, 23 (-48 to 185) 0.167
Male 40 17, 24 (-15 to 121)
ASA physical status Class 1 25 18, 18 (-23 to 69) 0.377
Class 2 38 17, 24 (-48 to 186)
Class 3 12 24, 36 (-1 to 121)
Preoperative chemotherapy Yes 37 21, 25 (-25 to 121) 0.384
No 38 15, 23 (-48 to 186)
Indications: metastases Yes 50 19, 25 (-25 to 121) 0.537
No 25 16, 22 (-48 to 186)
Portal vein embolization Yes 10 9, 18 (-48 to 91) 0.967
No 65 18, 25 (-25 to 186)
Preoperative splenomegaly Yes 18 7, 10 (-48 to 66) 0.695
No 57 20, 28 (-25 to 186)
Clamping Yes 33 18, 28 (-48 to 186) 0.691
No 42 18, 21 (-25 to 95)
Intraoperative blood transfusionsb Yes 4 -15, -11 (-48 to 32) 0.001
No 71 18, 26 (-25 to 186)
Resected portal branch Left 10 29, 30 (-14 to 95) 0.336
Right 52 18, 26 (-48 to 186)
No 13 13, 10 (-23 to 26)
Major hepatectomyb Yes 63 18, 27 (-48 to 186) 0.120
No 12 12, 10 (-23 to 26)
Liver steatosis of >30%b Yes 11 17, 51 (7–186) 0.013
No 64 18, 19 (-48 to 95)
Overall complications Yes 25 18, 27 (-48 to 121) 0.577
No 50 18, 22 (-25 to 186)
Major complications Yes 10 20, 26 (-48 to 95) 0.885
No 65 17, 23 (-25 to 186)
Infectious complications Yes 6 14, 14 (-48 to 87) 0.296
No 68 18, 25 (-25 to 186)
Postoperative hyperbilirubinaemiab Yes 38 23, 33 (-15 to 186) 0.012
No 31 13, 16 (-25 to 95)
Increased INRb Yes 6 46, 48 (5–91) 0.003
aFactors that achieved a P-value of <0.05 are statistically significant.
bFactors that achieved a P-value of <0.2 were introduced in a multiple linear regression with stepwise selection (R2 = 0.83).
ASA, American Society of Anesthesiologists; INR, international normalized ratio.
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maximum value of remnant liver VTTQ and postoperative peaks
in bilirubin,45 presumably because the bile canalicular networks
are initially disrupted at the beginning of the regeneration proc-
ess.47 Interestingly, in the current study, the postoperative peak in
bilirubin was an independent predictor of splenic hypertrophy,
suggesting that the disorganization of the hepatic lobular archi-
tecture may play a role in spleen enlargement. This may also
explain why the spleen increases in volume in the first postopera-
tive months and returns to a normal volume at the end of the liver
regeneration process.8
In conclusion, the current study showed that splenic hypertro-
phy was a common finding after liver resection, but occurred only
after major hepatectomy. This splenic enlargement was not lin-
early correlated to the extent of liver resection, whereas there was
a linear correlation between spleen and liver hypertrophy. This
correlation supports the hypothesis of a splenic action of hepatic
growth factors or a redistribution of total RES, rather than an
effect of reduction of the portal bed or hepatic outflow. A last
hypothesis was that splenic hypertrophy might reflect a disorgani-
zation of the hepatic lobular architecture at the beginning of the
liver regeneration process.
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